Key dates as US regulators weigh emergency use of vaccines
The next few weeks will likely see a lot of action as U.S. regulators assess COVID-19 vaccines and state officials get ready to start giving the shots to people
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The next few weeks will likely see a lot of action as U.S. regulators assess COVID-19 vaccines and state officials get ready to start giving the shots to people. Shots for at most 20 million people are expected by year’s end.
A timeline of what to expect in the coming days:
— Dec. 1: Centers for Disease Control and Prevention advisory committee votes on who should be first in line to receive vaccinations.
— Dec. 4: Deadline for states to submit requests for doses of the Pfizer/BioNTech vaccine and where they should be shipped.
— Dec. 10: Food and Drug Administration advisers meet to debate if there’s enough evidence for emergency use of the Pfizer vaccine. Sometime after the meeting, the FDA will weigh those recommendations in deciding whether to authorize emergency use.
— Dec. 11: Deadline for states to submit requests for doses of the Moderna vaccine and where they should be shipped.
— Dec. 17: FDA advisers meet to debate evidence behind the Moderna vaccine. The FDA will weigh those recommendations in deciding whether to authorize emergency use sometime after the meeting.
Once the FDA authorizes emergency use of either vaccine:
— Within 24 hours: “Phase 1a” of rollout begins. Private shippers would send shots to each state’s predetermined locations, such as hospitals. Health workers would give first shots to people per states' plans, with people working in health care likely at the front of the line.
— Second doses: For Pfizer’s vaccine, the second dose is given three weeks after the first. For Moderna’s, the second shot comes four weeks after the first.